BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

255 related articles for article (PubMed ID: 10027519)

  • 1. Cytokeratin 20: a marker for diagnosing Merkel cell carcinoma.
    Scott MP; Helm KF
    Am J Dermatopathol; 1999 Feb; 21(1):16-20. PubMed ID: 10027519
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cytokeratin 20 immunoreactivity distinguishes Merkel cell (primary cutaneous neuroendocrine) carcinomas and salivary gland small cell carcinomas from small cell carcinomas of various sites.
    Chan JK; Suster S; Wenig BM; Tsang WY; Chan JB; Lau AL
    Am J Surg Pathol; 1997 Feb; 21(2):226-34. PubMed ID: 9042291
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Analysis of thyroid transcription factor-1 and cytokeratin 20 separates merkel cell carcinoma from small cell carcinoma of lung.
    Hanly AJ; Elgart GW; Jorda M; Smith J; Nadji M
    J Cutan Pathol; 2000 Mar; 27(3):118-20. PubMed ID: 10728812
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cytokeratin staining in Merkel cell carcinoma: an immunohistochemical study of cytokeratins 5/6, 7, 17, and 20.
    Jensen K; Kohler S; Rouse RV
    Appl Immunohistochem Mol Morphol; 2000 Dec; 8(4):310-5. PubMed ID: 11127923
    [TBL] [Abstract][Full Text] [Related]  

  • 5. GATA3 Expression in Normal Skin and in Benign and Malignant Epidermal and Cutaneous Adnexal Neoplasms.
    Mertens RB; de Peralta-Venturina MN; Balzer BL; Frishberg DP
    Am J Dermatopathol; 2015 Dec; 37(12):885-91. PubMed ID: 26595821
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Merkel cell carcinoma can be distinguished from metastatic small cell carcinoma using antibodies to cytokeratin 20 and thyroid transcription factor 1.
    Leech SN; Kolar AJ; Barrett PD; Sinclair SA; Leonard N
    J Clin Pathol; 2001 Sep; 54(9):727-9. PubMed ID: 11533085
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunostaining for thyroid transcription factor 1 and cytokeratin 20 aids the distinction of small cell carcinoma from Merkel cell carcinoma, but not pulmonary from extrapulmonary small cell carcinomas.
    Cheuk W; Kwan MY; Suster S; Chan JK
    Arch Pathol Lab Med; 2001 Feb; 125(2):228-31. PubMed ID: 11175640
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Use of thyroid transcription factor 1, PE-10, and cytokeratins 7 and 20 in discriminating between primary lung carcinomas and metastatic lesions in fine-needle aspiration biopsy specimens.
    Chhieng DC; Cangiarella JF; Zakowski MF; Goswami S; Cohen JM; Yee HT
    Cancer; 2001 Oct; 93(5):330-6. PubMed ID: 11668468
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CD99 and cytokeratin-20 in small-cell and basaloid tumors of the skin.
    Nicholson SA; McDermott MB; Swanson PE; Wick MR
    Appl Immunohistochem Mol Morphol; 2000 Mar; 8(1):37-41. PubMed ID: 10937047
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Keratin 20: immunohistochemical marker for gastrointestinal, urothelial, and Merkel cell carcinomas.
    Miettinen M
    Mod Pathol; 1995 May; 8(4):384-8. PubMed ID: 7567935
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cytokeratin 20 is a general marker of cutaneous Merkel cells while certain neuronal proteins are absent.
    Moll I; Kuhn C; Moll R
    J Invest Dermatol; 1995 Jun; 104(6):910-5. PubMed ID: 7769257
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cytokeratin 5/6 immunostaining in cutaneous adnexal neoplasms and metastatic adenocarcinoma.
    Plumb SJ; Argenyi ZB; Stone MS; De Young BR
    Am J Dermatopathol; 2004 Dec; 26(6):447-51. PubMed ID: 15618924
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neurofilament is superior to cytokeratin 20 in supporting cutaneous origin for neuroendocrine carcinoma.
    Stanoszek LM; Chan MP; Palanisamy N; Carskadon S; Siddiqui J; Patel RM; Harms KL; Lowe L; Fullen DR; Harms PW
    Histopathology; 2019 Feb; 74(3):504-513. PubMed ID: 30239030
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cytokeratin and neurofilament protein staining in Merkel cell carcinoma of the small cell type and small cell carcinoma of the lung.
    Schmidt U; Müller U; Metz KA; Leder LD
    Am J Dermatopathol; 1998 Aug; 20(4):346-51. PubMed ID: 9700371
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Value of cytokeratin 20 stain in Merkel-cell carcinoma.
    Legier JF
    Diagn Cytopathol; 1998 Dec; 19(6):472. PubMed ID: 9839142
    [No Abstract]   [Full Text] [Related]  

  • 16. INSM1 Is More Sensitive and Interpretable than Conventional Immunohistochemical Stains Used to Diagnose Merkel Cell Carcinoma.
    Lilo MT; Chen Y; LeBlanc RE
    Am J Surg Pathol; 2018 Nov; 42(11):1541-1548. PubMed ID: 30080705
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An immunohistological study of cytokeratin 20 in human and mammalian oral epithelium.
    Barrett AW; Cort EM; Patel P; Berkovitz BK
    Arch Oral Biol; 2000 Oct; 45(10):879-87. PubMed ID: 10973561
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Value of thyroid transcription factor-1 immunostaining in distinguishing small cell lung carcinomas from other small cell carcinomas.
    Ordóñez NG
    Am J Surg Pathol; 2000 Sep; 24(9):1217-23. PubMed ID: 10976695
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Merkel cell carcinoma with eccrine differentiation: a clinicopathologic study of 7 cases.
    Saeb-Lima M; Montante-Montes de Oca D; Albores-Saavedra J
    Ann Diagn Pathol; 2008 Dec; 12(6):410-4. PubMed ID: 18995205
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cytokeratin 7 and cytokeratin 20 expression in epithelial neoplasms: a survey of 435 cases.
    Chu P; Wu E; Weiss LM
    Mod Pathol; 2000 Sep; 13(9):962-72. PubMed ID: 11007036
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.